The Efficacy of Scalp Cooling in Patients Receiving Chemotherapy for Primary Gynecologic Cancers: A Randomized Controlled Trial
March 2026
in “
Scientific Reports
”
TLDR Scalp cooling reduces hair loss and improves quality of life during chemotherapy.
The CHARM study investigated the efficacy of scalp cooling in preventing chemotherapy-induced alopecia (CIA) in women with primary gynecologic cancers undergoing carboplatin and paclitaxel treatment. In this randomized controlled trial, 86 women participated, with 44 in the scalp cooling group and 42 in the control group. The intervention group showed a significantly higher success rate in hair preservation (29.6% vs. 0%) and experienced better global health status, physical functioning, and role functioning during chemotherapy. They also had lower psychological distress and PHQ-ADS scores after cycle 2 and post-chemotherapy. Despite these benefits, the intervention group had a 30% drop-out rate. The study concludes that scalp cooling can reduce CIA and improve quality of life, but further efforts are needed to enhance acceptance and compliance, particularly in Asian populations.